Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 4/20 | 0.34 |
| ▸ | CNR1 | P21554 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TACR3 | P29371 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610851 | 0.95 | TACR3 (0.36) | MAPTCNR2KMT2AL3MBTL1MEN1 | |
| SCHEMBL1609688 | 0.89 | HTR2A (0.35) | MAPTKMT2AL3MBTL1MEN1ATM | |
| SCHEMBL1610411 | 0.82 | HTR2A (0.37) | MAPTKMT2AL3MBTL1KDM4EMEN1 | |
| SCHEMBL1610858 | 0.81 | PPARG (0.33) | MAPTCNR2CNR1KMT2AL3MBTL1 | |
| SCHEMBL8207670 | 0.80 | MAPT (0.43) | MAPTKMT2AL3MBTL1KDM4EMEN1 | |
| SCHEMBL10361949 | 0.79 | MAPT (0.45) | MAPTKMT2AL3MBTL1KDM4EMEN1 | |
| SCHEMBL1612032 | 0.79 | KDM4E (0.40) | CNR2CNR1KMT2AL3MBTL1KDM4E | |
| SCHEMBL1611406 | 0.78 | UGT2B7 (0.37) | KMT2AMEN1NPC1ATMNPSR1 | |
| SCHEMBL22288178 | 0.78 | MAPT (0.41) | MAPTCNR2CNR1KMT2AL3MBTL1 | |
| SCHEMBL2113581 | 0.78 | MAPT (0.41) | MAPTCNR2CNR1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | MAPT 3838/4885CNR2 3192/4885CNR1 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.